Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey

Background: Data on the incidence of neuropathic pain (NeP) in Austria, its general characteristics and consequences for the quality of life (QOL) are still lacking. The prevalence in the United Kingdom is 8%. Methods: A representative survey (n=7707) was carried out. Patients with NeP were identifi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta anaesthesiologica Scandinavica 2008-01, Vol.52 (1), p.132-136
Hauptverfasser: GUSTORFF, B., DORNER, T., LIKAR, R., GRISOLD, W., LAWRENCE, K., SCHWARZ, F., RIEDER, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 136
container_issue 1
container_start_page 132
container_title Acta anaesthesiologica Scandinavica
container_volume 52
creator GUSTORFF, B.
DORNER, T.
LIKAR, R.
GRISOLD, W.
LAWRENCE, K.
SCHWARZ, F.
RIEDER, A.
description Background: Data on the incidence of neuropathic pain (NeP) in Austria, its general characteristics and consequences for the quality of life (QOL) are still lacking. The prevalence in the United Kingdom is 8%. Methods: A representative survey (n=7707) was carried out. Patients with NeP were identified using previously validated criteria and subsequently asked to complete a questionnaire on QOL and detailed pain characteristics. Results: The prevalence of NeP was 3.3% (n=260). A higher prevalence was found in 41–50‐year‐olds (26%) and 51–60 year olds (24%). Pain was long lasting (>1 year: 66%; >5 years: 41%) and severe at onset (mean 6.8; numerical rating scale) as well as later (mean 4.7; 20% 8 or higher). Strong or predominant restriction of daily activities was reported in 65%, strong or predominant sleep disturbances in 60%, feelings of depression in 34% and anxiety in 25%. Conclusion: For the first time, data on the prevalence of NeP in Austria are available. Pain patterns in those affected are characteristic and impact on QOL as well as pain intensity are severe.
doi_str_mv 10.1111/j.1399-6576.2007.01486.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70177743</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70177743</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4606-edd33510baf838b09fc3292f46370d287af2996c199d91167dfed2749c0b07833</originalsourceid><addsrcrecordid>eNqNkE1vEzEQhi0EomnhLyBf4LZbf2zsNRKHKIUWqWorUcTRcrxj4eDsbu3dNPn39TZRe8UXe-TnmRm9CGFKSprP-bqkXKlCzKUoGSGyJLSqRbl7g2YvH2_RjBBCizmV7ASdprTOJa-Ueo9OqFRSMEZmqLuLsDUBWgu4czhBcEWEvosDNLiFMXa9Gf56i3vjW2zaBvtNb-yAuxY_jCb4YT95wTv4ig3uY5d6sIPfAs5tIiRoB_NcpjFuYf8BvXMmJPh4vM_Q7x_f75dXxfXt5c_l4rqwlSCigKbhfE7Jyria1yuinOVMMVcJLknDamkcU0pYqlSjKBWycdAwWSlLVkTWnJ-hL4e-eaOHEdKgNz5ZCMG00I1JS0KllNUE1gfQ5tVTBKf76Dcm7jUlegpbr_WUqZ4y1VPY-jlsvcvqp-OMcbWB5lU8ppuBz0fAJGuCi6a1Pr1ySqmKMZa5bwfu0QfY__cCerH4Nb2yXxx8nwbYvfgm_tNCcjnXf24udbW8uL-rLrhe8idRaqrb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70177743</pqid></control><display><type>article</type><title>Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>GUSTORFF, B. ; DORNER, T. ; LIKAR, R. ; GRISOLD, W. ; LAWRENCE, K. ; SCHWARZ, F. ; RIEDER, A.</creator><creatorcontrib>GUSTORFF, B. ; DORNER, T. ; LIKAR, R. ; GRISOLD, W. ; LAWRENCE, K. ; SCHWARZ, F. ; RIEDER, A.</creatorcontrib><description>Background: Data on the incidence of neuropathic pain (NeP) in Austria, its general characteristics and consequences for the quality of life (QOL) are still lacking. The prevalence in the United Kingdom is 8%. Methods: A representative survey (n=7707) was carried out. Patients with NeP were identified using previously validated criteria and subsequently asked to complete a questionnaire on QOL and detailed pain characteristics. Results: The prevalence of NeP was 3.3% (n=260). A higher prevalence was found in 41–50‐year‐olds (26%) and 51–60 year olds (24%). Pain was long lasting (&gt;1 year: 66%; &gt;5 years: 41%) and severe at onset (mean 6.8; numerical rating scale) as well as later (mean 4.7; 20% 8 or higher). Strong or predominant restriction of daily activities was reported in 65%, strong or predominant sleep disturbances in 60%, feelings of depression in 34% and anxiety in 25%. Conclusion: For the first time, data on the prevalence of NeP in Austria are available. Pain patterns in those affected are characteristic and impact on QOL as well as pain intensity are severe.</description><identifier>ISSN: 0001-5172</identifier><identifier>EISSN: 1399-6576</identifier><identifier>DOI: 10.1111/j.1399-6576.2007.01486.x</identifier><identifier>PMID: 17976220</identifier><identifier>CODEN: AANEAB</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Absenteeism ; Activities of Daily Living ; Adult ; Aged ; Analgesics - therapeutic use ; Anesthesia ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Austria ; Austria - epidemiology ; Biological and medical sciences ; Chronic Disease ; chronic pain ; Combined Modality Therapy ; Depression ; Fear ; Female ; Health Surveys ; Humans ; Male ; Medical sciences ; Middle Aged ; Neuralgia - complications ; Neuralgia - epidemiology ; Neuralgia - psychology ; Neuralgia - therapy ; Neuropathic pain ; Patient Acceptance of Health Care - statistics &amp; numerical data ; Physical Therapy Modalities - utilization ; Prevalence ; Prospective Studies ; Quality of Life ; Sleep Disorders, Intrinsic - epidemiology ; Sleep Disorders, Intrinsic - etiology</subject><ispartof>Acta anaesthesiologica Scandinavica, 2008-01, Vol.52 (1), p.132-136</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4606-edd33510baf838b09fc3292f46370d287af2996c199d91167dfed2749c0b07833</citedby><cites>FETCH-LOGICAL-c4606-edd33510baf838b09fc3292f46370d287af2996c199d91167dfed2749c0b07833</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1399-6576.2007.01486.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1399-6576.2007.01486.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,4028,27932,27933,27934,45583,45584</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19994222$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17976220$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GUSTORFF, B.</creatorcontrib><creatorcontrib>DORNER, T.</creatorcontrib><creatorcontrib>LIKAR, R.</creatorcontrib><creatorcontrib>GRISOLD, W.</creatorcontrib><creatorcontrib>LAWRENCE, K.</creatorcontrib><creatorcontrib>SCHWARZ, F.</creatorcontrib><creatorcontrib>RIEDER, A.</creatorcontrib><title>Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey</title><title>Acta anaesthesiologica Scandinavica</title><addtitle>Acta Anaesthesiol Scand</addtitle><description>Background: Data on the incidence of neuropathic pain (NeP) in Austria, its general characteristics and consequences for the quality of life (QOL) are still lacking. The prevalence in the United Kingdom is 8%. Methods: A representative survey (n=7707) was carried out. Patients with NeP were identified using previously validated criteria and subsequently asked to complete a questionnaire on QOL and detailed pain characteristics. Results: The prevalence of NeP was 3.3% (n=260). A higher prevalence was found in 41–50‐year‐olds (26%) and 51–60 year olds (24%). Pain was long lasting (&gt;1 year: 66%; &gt;5 years: 41%) and severe at onset (mean 6.8; numerical rating scale) as well as later (mean 4.7; 20% 8 or higher). Strong or predominant restriction of daily activities was reported in 65%, strong or predominant sleep disturbances in 60%, feelings of depression in 34% and anxiety in 25%. Conclusion: For the first time, data on the prevalence of NeP in Austria are available. Pain patterns in those affected are characteristic and impact on QOL as well as pain intensity are severe.</description><subject>Absenteeism</subject><subject>Activities of Daily Living</subject><subject>Adult</subject><subject>Aged</subject><subject>Analgesics - therapeutic use</subject><subject>Anesthesia</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Austria</subject><subject>Austria - epidemiology</subject><subject>Biological and medical sciences</subject><subject>Chronic Disease</subject><subject>chronic pain</subject><subject>Combined Modality Therapy</subject><subject>Depression</subject><subject>Fear</subject><subject>Female</subject><subject>Health Surveys</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neuralgia - complications</subject><subject>Neuralgia - epidemiology</subject><subject>Neuralgia - psychology</subject><subject>Neuralgia - therapy</subject><subject>Neuropathic pain</subject><subject>Patient Acceptance of Health Care - statistics &amp; numerical data</subject><subject>Physical Therapy Modalities - utilization</subject><subject>Prevalence</subject><subject>Prospective Studies</subject><subject>Quality of Life</subject><subject>Sleep Disorders, Intrinsic - epidemiology</subject><subject>Sleep Disorders, Intrinsic - etiology</subject><issn>0001-5172</issn><issn>1399-6576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1vEzEQhi0EomnhLyBf4LZbf2zsNRKHKIUWqWorUcTRcrxj4eDsbu3dNPn39TZRe8UXe-TnmRm9CGFKSprP-bqkXKlCzKUoGSGyJLSqRbl7g2YvH2_RjBBCizmV7ASdprTOJa-Ueo9OqFRSMEZmqLuLsDUBWgu4czhBcEWEvosDNLiFMXa9Gf56i3vjW2zaBvtNb-yAuxY_jCb4YT95wTv4ig3uY5d6sIPfAs5tIiRoB_NcpjFuYf8BvXMmJPh4vM_Q7x_f75dXxfXt5c_l4rqwlSCigKbhfE7Jyria1yuinOVMMVcJLknDamkcU0pYqlSjKBWycdAwWSlLVkTWnJ-hL4e-eaOHEdKgNz5ZCMG00I1JS0KllNUE1gfQ5tVTBKf76Dcm7jUlegpbr_WUqZ4y1VPY-jlsvcvqp-OMcbWB5lU8ppuBz0fAJGuCi6a1Pr1ySqmKMZa5bwfu0QfY__cCerH4Nb2yXxx8nwbYvfgm_tNCcjnXf24udbW8uL-rLrhe8idRaqrb</recordid><startdate>200801</startdate><enddate>200801</enddate><creator>GUSTORFF, B.</creator><creator>DORNER, T.</creator><creator>LIKAR, R.</creator><creator>GRISOLD, W.</creator><creator>LAWRENCE, K.</creator><creator>SCHWARZ, F.</creator><creator>RIEDER, A.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200801</creationdate><title>Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey</title><author>GUSTORFF, B. ; DORNER, T. ; LIKAR, R. ; GRISOLD, W. ; LAWRENCE, K. ; SCHWARZ, F. ; RIEDER, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4606-edd33510baf838b09fc3292f46370d287af2996c199d91167dfed2749c0b07833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Absenteeism</topic><topic>Activities of Daily Living</topic><topic>Adult</topic><topic>Aged</topic><topic>Analgesics - therapeutic use</topic><topic>Anesthesia</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Austria</topic><topic>Austria - epidemiology</topic><topic>Biological and medical sciences</topic><topic>Chronic Disease</topic><topic>chronic pain</topic><topic>Combined Modality Therapy</topic><topic>Depression</topic><topic>Fear</topic><topic>Female</topic><topic>Health Surveys</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neuralgia - complications</topic><topic>Neuralgia - epidemiology</topic><topic>Neuralgia - psychology</topic><topic>Neuralgia - therapy</topic><topic>Neuropathic pain</topic><topic>Patient Acceptance of Health Care - statistics &amp; numerical data</topic><topic>Physical Therapy Modalities - utilization</topic><topic>Prevalence</topic><topic>Prospective Studies</topic><topic>Quality of Life</topic><topic>Sleep Disorders, Intrinsic - epidemiology</topic><topic>Sleep Disorders, Intrinsic - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GUSTORFF, B.</creatorcontrib><creatorcontrib>DORNER, T.</creatorcontrib><creatorcontrib>LIKAR, R.</creatorcontrib><creatorcontrib>GRISOLD, W.</creatorcontrib><creatorcontrib>LAWRENCE, K.</creatorcontrib><creatorcontrib>SCHWARZ, F.</creatorcontrib><creatorcontrib>RIEDER, A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta anaesthesiologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GUSTORFF, B.</au><au>DORNER, T.</au><au>LIKAR, R.</au><au>GRISOLD, W.</au><au>LAWRENCE, K.</au><au>SCHWARZ, F.</au><au>RIEDER, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey</atitle><jtitle>Acta anaesthesiologica Scandinavica</jtitle><addtitle>Acta Anaesthesiol Scand</addtitle><date>2008-01</date><risdate>2008</risdate><volume>52</volume><issue>1</issue><spage>132</spage><epage>136</epage><pages>132-136</pages><issn>0001-5172</issn><eissn>1399-6576</eissn><coden>AANEAB</coden><abstract>Background: Data on the incidence of neuropathic pain (NeP) in Austria, its general characteristics and consequences for the quality of life (QOL) are still lacking. The prevalence in the United Kingdom is 8%. Methods: A representative survey (n=7707) was carried out. Patients with NeP were identified using previously validated criteria and subsequently asked to complete a questionnaire on QOL and detailed pain characteristics. Results: The prevalence of NeP was 3.3% (n=260). A higher prevalence was found in 41–50‐year‐olds (26%) and 51–60 year olds (24%). Pain was long lasting (&gt;1 year: 66%; &gt;5 years: 41%) and severe at onset (mean 6.8; numerical rating scale) as well as later (mean 4.7; 20% 8 or higher). Strong or predominant restriction of daily activities was reported in 65%, strong or predominant sleep disturbances in 60%, feelings of depression in 34% and anxiety in 25%. Conclusion: For the first time, data on the prevalence of NeP in Austria are available. Pain patterns in those affected are characteristic and impact on QOL as well as pain intensity are severe.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17976220</pmid><doi>10.1111/j.1399-6576.2007.01486.x</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-5172
ispartof Acta anaesthesiologica Scandinavica, 2008-01, Vol.52 (1), p.132-136
issn 0001-5172
1399-6576
language eng
recordid cdi_proquest_miscellaneous_70177743
source MEDLINE; Access via Wiley Online Library
subjects Absenteeism
Activities of Daily Living
Adult
Aged
Analgesics - therapeutic use
Anesthesia
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Austria
Austria - epidemiology
Biological and medical sciences
Chronic Disease
chronic pain
Combined Modality Therapy
Depression
Fear
Female
Health Surveys
Humans
Male
Medical sciences
Middle Aged
Neuralgia - complications
Neuralgia - epidemiology
Neuralgia - psychology
Neuralgia - therapy
Neuropathic pain
Patient Acceptance of Health Care - statistics & numerical data
Physical Therapy Modalities - utilization
Prevalence
Prospective Studies
Quality of Life
Sleep Disorders, Intrinsic - epidemiology
Sleep Disorders, Intrinsic - etiology
title Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T13%3A02%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20self-reported%20neuropathic%20pain%20and%20impact%20on%20quality%20of%20life:%20a%20prospective%20representative%20survey&rft.jtitle=Acta%20anaesthesiologica%20Scandinavica&rft.au=GUSTORFF,%20B.&rft.date=2008-01&rft.volume=52&rft.issue=1&rft.spage=132&rft.epage=136&rft.pages=132-136&rft.issn=0001-5172&rft.eissn=1399-6576&rft.coden=AANEAB&rft_id=info:doi/10.1111/j.1399-6576.2007.01486.x&rft_dat=%3Cproquest_cross%3E70177743%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70177743&rft_id=info:pmid/17976220&rfr_iscdi=true